These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3819393)

  • 1. NK susceptibility varies inversely with target cell class I HLA antigen expression.
    Storkus WJ; Howell DN; Salter RD; Dawson JR; Cresswell P
    J Immunol; 1987 Mar; 138(6):1657-9. PubMed ID: 3819393
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
    Fletcher JM; Prentice HG; Grundy JE
    J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Direct demonstration using beta 2-microglobulin-transfected Daudi cells.
    Quillet A; Presse F; Marchiol-Fournigault C; Harel-Bellan A; Benbunan M; Ploegh H; Fradelizi D
    J Immunol; 1988 Jul; 141(1):17-20. PubMed ID: 3288697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.
    Llano M; Gumá M; Ortega M; Angulo A; López-Botet M
    Eur J Immunol; 2003 Oct; 33(10):2744-54. PubMed ID: 14515258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance against natural killer cell cytotoxicity: analysis of mechanisms.
    Hasenkamp J; Borgerding A; Wulf G; Uhrberg M; Jung W; Dingeldein S; Truemper L; Glass B
    Scand J Immunol; 2006 Oct; 64(4):444-9. PubMed ID: 16970688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1.
    Poehlmann TG; Schaumann A; Busch S; Fitzgerald JS; Aguerre-Girr M; Le Bouteiller P; Schleussner E; Markert UR
    Am J Reprod Immunol; 2006; 56(5-6):275-85. PubMed ID: 17076671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the role of class I and class II HLA antigens in the lytic function of a cloned line of human natural killer cells.
    Kornbluth J; Spear B; Raab SS; Wilson DB
    J Immunol; 1985 Feb; 134(2):728-35. PubMed ID: 3965573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity.
    Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S
    Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of HLA expression in human cytomegalovirus immune evasion.
    Lin A; Xu H; Yan W
    Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysis.
    Miyagawa S; Nakai R; Matsunami K; Kusama T; Shirakura R
    Transpl Immunol; 2003; 11(2):147-53. PubMed ID: 12799197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line.
    Howell DN; Andreotti PE; Dawson JR; Cresswell P
    J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse.
    Yu Y; Wang Y; Feng M
    Hum Immunol; 2008 Jan; 69(1):16-23. PubMed ID: 18295671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS; Schoon RA; Leibson PJ
    J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.